The effect of glycine administration on the characteristics of physiological systems in human adults: A systematic review

Zhavoronkov A, Cantor CR. “Methods for structuring scientific knowledge from many areas related to aging research,” (in eng). PLoS One. 2011;6(7):e22597. https://doi.org/10.1371/journal.pone.0022597.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Correia-Melo C, Passos JF. “Mitochondria: Are they causal players in cellular senescence?,” (in eng). Biochim Biophys Acta. 2015;1847(11):1373–9. https://doi.org/10.1016/j.bbabio.2015.05.017.

Article  CAS  PubMed  Google Scholar 

Riera CE, Dillin A. “Tipping the metabolic scales towards increased longevity in mammals,” (in eng). Nat Cell Biol. 2015;17(3):196–203. https://doi.org/10.1038/ncb3107.

Article  CAS  PubMed  Google Scholar 

Moskalev AA, Aliper AM, Smit-McBride Z, Buzdin A, Zhavoronkov A. “Genetics and epigenetics of aging and longevity,” (in eng). Cell Cycle. 2014;13(7):1063–77. https://doi.org/10.4161/cc.28433.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beard JR, Bloom DE. “Towards a comprehensive public health response to population ageing,” (in eng). Lancet. 2015;385(9968):658–61. https://doi.org/10.1016/s0140-6736(14)61461-6.

Article  PubMed  Google Scholar 

Fried LP, et al. “Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment,” (in eng). J Gerontol A Biol Sci Med Sci. 2009;64(10):1049–57. https://doi.org/10.1093/gerona/glp076.

Article  PubMed  Google Scholar 

Moskalev A, et al. Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease, (in eng). Aging (Albany NY). 2015;7(9):616–28. https://doi.org/10.18632/aging.100799.

Article  CAS  PubMed  Google Scholar 

Wang W, Wu Z, Dai Z, Yang Y, Wang J, Wu G. “Glycine metabolism in animals and humans: implications for nutrition and health,” (in eng). Amino Acids. 2013;45(3):463–77. https://doi.org/10.1007/s00726-013-1493-1.

Article  CAS  PubMed  Google Scholar 

Alarcon-Aguilar FJ, et al. “Glycine regulates the production of pro-inflammatory cytokines in lean and monosodium glutamate-obese mice,” (in eng). Eur J Pharmacol. 2008;599(1–3):152–8. https://doi.org/10.1016/j.ejphar.2008.09.047.

Article  CAS  PubMed  Google Scholar 

Zhong Z, et al. “L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent,” (in eng). Curr Opin Clin Nutr Metab Care. 2003;6(2):229–40. https://doi.org/10.1097/00075197-200303000-00013.

Article  CAS  PubMed  Google Scholar 

Alves A, Bassot A, Bulteau AL, Pirola L, Morio B. “Glycine metabolism and its alterations in obesity and metabolic diseases,” (in eng). Nutrients. 2019;11(6):1356. https://doi.org/10.3390/nu11061356.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Díaz-Flores M, et al. “Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure,” (in eng). Can J Physiol Pharmacol. 2013;91(10):855–60. https://doi.org/10.1139/cjpp-2012-0341.

Article  CAS  PubMed  Google Scholar 

Cruz M, et al. “Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes,” (in eng). J Endocrinol Invest. 2008;31(8):694–9. https://doi.org/10.1007/bf03346417.

Article  CAS  PubMed  Google Scholar 

Matilla B, Mauriz JL, Culebras JM, González-Gallego J, González P. “[Glycine: a cell-protecting anti-oxidant nutrient],” (in spa). Nutr Hosp. 2002;17(1):2–9 (La glicina: un nutriente antioxidante protector celular).

CAS  PubMed  Google Scholar 

de Koning TJ, Snell K, Duran M, Berger R, Poll-The BT, Surtees R. “L-serine in disease and development,” (in eng). Biochem J. 2003;371(Pt 3):653–61. https://doi.org/10.1042/bj20021785.

Article  PubMed  PubMed Central  Google Scholar 

Lewis RM, Godfrey KM, Jackson AA, Cameron IT, Hanson MA. “Low serine hydroxymethyltransferase activity in the human placenta has important implications for fetal glycine supply,” (in eng). J Clin Endocrinol Metab. 2005;90(3):1594–8. https://doi.org/10.1210/jc.2004-0317.

Article  CAS  PubMed  Google Scholar 

Liu YJ, et al. “Glycine promotes longevity in Caenorhabditis elegans in a methionine cycle-dependent fashion,” (in eng). PLoS Genet. 2019;15(3):e1007633. https://doi.org/10.1371/journal.pgen.1007633.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edwards C, et al. “Mechanisms of amino acid-mediated lifespan extension in Caenorhabditis elegans,” (in eng). BMC Genet. 2015;16(1):8. https://doi.org/10.1186/s12863-015-0167-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brind J, et al. Dietary glycine supplementation mimics lifespan extension by dietary methionine restriction in Fisher 344 rats. FASEB J. 2011;25(S1):528.2-528.2. https://doi.org/10.1096/fasebj.25.1_supplement.528.2.

Article  Google Scholar 

Miller RA, et al. “Glycine supplementation extends lifespan of male and female mice,” (in eng). Aging Cell. 2019;18(3):e12953. https://doi.org/10.1111/acel.12953.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sterne JAC, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.

Article  PubMed  Google Scholar 

Higgins JPT, Sterne J, et al. (eds) "Revised Cochrane risk of bias tool for randomized trials (RoB 2) additional considerations for crossover trials." https://www.riskofbias.info/welcome/rob-2-0-tool/rob-2-for-crossover-trials. (Accessed 29 April 2022).

Sterne JA, et al. “ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions,” (in eng). BMJ. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919.

Article  PubMed  PubMed Central  Google Scholar 

González-Ortiz M, Medina-Santillán R, Martínez-Abundis E, von Drateln CR. “Effect of glycine on insulin secretion and action in healthy first-degree relatives of type 2 diabetes mellitus patients,” (in eng). Horm Metab Res. 2001;33(6):358–60. https://doi.org/10.1055/s-2001-15421.

Article  PubMed  Google Scholar 

Daly JM, et al. “Immune and metabolic effects of arginine in the surgical patient,” (in eng). Ann Surg. 1988;208(4):512–23. https://doi.org/10.1097/00000658-198810000-00013.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aliyev NA, Aliyev ZN. “Application of glycine in acute alcohol hallucinosis,” (in eng). Hum Psychopharmacol. 2005;20(8):591–4. https://doi.org/10.1002/hup.735.

Article  CAS  PubMed  Google Scholar 

Greenberg WM, et al. “Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults,” (in eng). J Psychiatr Res. 2009;43(6):664–70. https://doi.org/10.1016/j.jpsychires.2008.10.007.

Article  PubMed  Google Scholar 

Greenwood LM, et al. “The effects of glycine on auditory mismatch negativity in schizophrenia,” (in eng). Schizophr Res. 2018;191:61–9. https://doi.org/10.1016/j.schres.2017.05.031.

Article  PubMed  Google Scholar 

Potkin SG, Jin Y, Bunney BG, Costa J, Gulasekaram B. “Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia,” (in eng). Am J Psychiatry. 1999;156(1):145–7. https://doi.org/10.1176/ajp.156.1.145.

Article  CAS  PubMed  Google Scholar 

Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP. “Amelioration of negative symptoms in schizophrenia by glycine,” (in eng). Am J Psychiatry. 1994;151(8):1234–6. https://doi.org/10.1176/ajp.151.8.1234.

Article  CAS  PubMed  Google Scholar 

Serrita J, Ralevski E, Yoon G, Petrakis I. “A Pilot Randomized, Placebo-Controlled Trial of Glycine for Treatment of Schizophrenia and Alcohol Dependence,” (in eng). J Dual Diagn. 2019;15(1):46–55. https://doi.org/10.1080/15504263.2018.1549764.

Article  PubMed  Google Scholar 

Gusev EI, et al. “Neuroprotective effects of glycine for therapy of acute ischaemic stroke,” (in eng). Cerebrovasc Dis. 2000;10(1):49–60. https://doi.org/10.1159/000016025.

Article  CAS  PubMed  Google Scholar 

Khan M, et al. “Oral administration of glycine in the prevention of restenosis after coronary angioplasty. A double blind placebo controlled randomized feasibility trial evaluating safety and efficacy of glycine in the prevention of restenosis after angioplasty,” (in eng). Acute Card Care. 2006;8(1):58–64. https://doi.org/10.1080/14628840600643383.

Article  PubMed  Google Scholar 

Peng X, Yan H, You Z, Wang P, Wang S. “Glutamine granule-supplemented enteral nutrition maintains immunological function in severely burned patients,” (in eng). Burns. 2006;32(5):589–93. https://doi.org/10.1016/j.burns.2005.11.020.

Article  PubMed  Google Scholar 

D’Angelo A, Valsecchi L. “High dose antithrombin supplementation in early preeclampsia: A randomized, double blind, placebo-controlled study,” (in eng). Thromb Res. 2016;140:7–13. https://doi.org/10.1016/j.thromres.2016.01.024.

Comments (0)

No login
gif